Indefinite Delivery Contract SPE2DX15D5023

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The single-award IDC, valued at up to $4,999,999.00, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract scope includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas such as cardiovascular health, diabetes management, mental health, pain management, and infectious disease prevention. The IDC serves as the primary vehicle for the DLA to efficiently procure essential medical commodities for military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

The contract has a period of performance through December 31, 2025, and there is no set-aside designation, indicating open competition. The parent company, Cencora, Inc., doing business as Amerisourcebergen, holds a larger $999,999,999.00 IDC with the DLA Troop Support Medical, demonstrating the company's significant capacity to meet the diverse pharmaceutical needs of the Department of Defense on a large scale. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, for similar medical products and prescription drugs.